<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
<channel>


<title>aktiencheck.de - Forum - SCANSOFT INC.     DL-,001</title>
<link>http://www.aktiencheck.de</link>
<description>aktiencheck.de</description>
<language></language>
<copyright>aktiencheck.de</copyright>
<lastBuildDate>Thu, 23 Apr 2026 11:39:32 +0200</lastBuildDate>
<ttl>2</ttl>








<item>
<title>HAMSI wird</title>
<link>http://www.aktiencheck.de/forum/HAMSI_wird-919491-t205658</link>
<guid>http://www.aktiencheck.de/forum/HAMSI_wird-919491-t205658</guid>
<description>stehen gerade bei 3,7$, 
aber wenn um 17,30 Uhr Germ. nichts geht würde ich mal überlegen für welchen Preis du wieder rein willst. [&lt;a href=&#034;http://www.aktiencheck.de/forum/HAMSI_wird-919491-t205658&#034;&gt;mehr&lt;/a&gt;]</description>
</item>







<item>
<title>Hallo Nachteulen ! Was haltet ihr von "SCLN" (SciClone) ?</title>
<link>http://www.aktiencheck.de/forum/Hallo_Nachteulen_Was_haltet_ihr_von_SCLN_SciClone-919491-t34630</link>
<guid>http://www.aktiencheck.de/forum/Hallo_Nachteulen_Was_haltet_ihr_von_SCLN_SciClone-919491-t34630</guid>
<description>Heute Quartalsergebnisse!, SciClone Reports Second QuarterResults; Record ZADAXIN Sales of $16.2 Million and Net Income of $5.1Million

Business Editors/Health/Medical Writers
BIOWIRE2K

SAN MATEO, Calif.--(BUSINESS WIRE)--July 28, 2003--SciClonePharmaceuticals, Inc. (Nasdaq:SCLN) today reported net income of$5,124,000, or $0.13 per fully diluted share, for the second quarterended June 30, 2003. Revenues from sales of ZADAXIN(R), the company´slead immune system enhancer drug, reached a record $16,207,000, drivenprimarily by a significant unanticipated surge in orders related tothe SARS epidemic in China last April. [&lt;a href=&#034;http://www.aktiencheck.de/forum/Hallo_Nachteulen_Was_haltet_ihr_von_SCLN_SciClone-919491-t34630&#034;&gt;mehr&lt;/a&gt;]</description>
</item>

</channel>
</rss>







